Circulating RANKL and RANKL/OPG and breast cancer risk by ER and PR subtype: Results from the EPIC cohort.
Authors:
Sarink D, Schock H, Johnson T, Overvad K, Holm M, Tjonneland A, Boutron-Ruault MC, His M, Kvaskoff M, Boeing H, Lagiou P, Papatesta EM, Trichopoulou A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HBA, van Gils CH, Peeters PH, Weiderpass E, Agudo A, Sanchez MJ, Chirlaque MD, Ardanaz E, Amiano P, Khaw KT, Travis RC, Dossus L, Gunter MJ, Rinaldi S, Merritt MA, Riboli E, Kaaks R, Fortner RT.
Source:
Cancer Prev Res (Phila) 2017; 10: 525-534 (IF 3.985)